Literature DB >> 26541462

Amyloid Fibres: Inert End-Stage Aggregates or Key Players in Disease?

Kevin W Tipping1, Patricija van Oosten-Hawle1, Eric W Hewitt1, Sheena E Radford2.   

Abstract

The formation of amyloid fibres is a hallmark of amyloid disorders. Nevertheless, the lack of correlation between fibre load and disease as observed, for example, in Alzheimer's disease, means that fibres are considered secondary contributors to the onset of cellular dysfunction. Instead, soluble intermediates of amyloid assembly are often described as the agents of toxicity. Here, we discuss recent experimental discoveries which suggest that amyloid fibres should be considered as disease-relevant species that can mediate a range of pathological processes. These include disruption of biological membranes, secondary nucleation, amyloid aggregate transmission, and the disruption of protein homeostasis (proteostasis). Thus, a greater understanding of amyloid fibre biology could enhance prospects of developing therapeutic interventions against this devastating class of protein-misfolding disorders.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  amyloid; disease; fibres; transmission

Mesh:

Substances:

Year:  2015        PMID: 26541462     DOI: 10.1016/j.tibs.2015.10.002

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  37 in total

1.  A KLVFFAE-Derived Peptide Probe for Detection of Alpha-Synuclein Fibrils.

Authors:  Amy Wood; Edward Chau; Yanxi Yang; Jin Ryoun Kim
Journal:  Appl Biochem Biotechnol       Date:  2019-11-27       Impact factor: 2.926

Review 2.  Insights into protein misfolding and aggregation enabled by solid-state NMR spectroscopy.

Authors:  Patrick C A van der Wel
Journal:  Solid State Nucl Magn Reson       Date:  2017-10-04       Impact factor: 2.293

3.  Quantitative Characterization of Metastability and Heterogeneity of Amyloid Aggregates.

Authors:  Timir Baran Sil; Bankanidhi Sahoo; Subhas Chandra Bera; Kanchan Garai
Journal:  Biophys J       Date:  2018-02-27       Impact factor: 4.033

4.  Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis.

Authors:  Shobini Jayaraman; Donald L Gantz; Christian Haupt; Olga Gursky
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-25       Impact factor: 11.205

5.  Cadmium Causes Misfolding and Aggregation of Cytosolic Proteins in Yeast.

Authors:  Therese Jacobson; Smriti Priya; Sandeep K Sharma; Stefanie Andersson; Sofia Jakobsson; Robbe Tanghe; Arghavan Ashouri; Sebastien Rauch; Pierre Goloubinoff; Philipp Christen; Markus J Tamás
Journal:  Mol Cell Biol       Date:  2017-08-11       Impact factor: 4.272

6.  High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidogenic proteins.

Authors:  Lisa Vincenz-Donnelly; Hauke Holthusen; Roman Körner; Erik C Hansen; Jenny Presto; Jan Johansson; Ritwick Sawarkar; F Ulrich Hartl; Mark S Hipp
Journal:  EMBO J       Date:  2017-12-15       Impact factor: 11.598

7.  Glial Draper Rescues Aβ Toxicity in a Drosophila Model of Alzheimer's Disease.

Authors:  Arpita Ray; Sean D Speese; Mary A Logan
Journal:  J Neurosci       Date:  2017-11-06       Impact factor: 6.167

8.  Preparation and Screening of Catalytic Amyloid Assemblies.

Authors:  Zsofia Lengyel; Caroline M Rufo; Ivan V Korendovych
Journal:  Methods Mol Biol       Date:  2018

Review 9.  The proteostasis network and its decline in ageing.

Authors:  Mark S Hipp; Prasad Kasturi; F Ulrich Hartl
Journal:  Nat Rev Mol Cell Biol       Date:  2019-07       Impact factor: 94.444

10.  Molecular and structural architecture of polyQ aggregates in yeast.

Authors:  Anselm Gruber; Daniel Hornburg; Matthias Antonin; Natalie Krahmer; Javier Collado; Miroslava Schaffer; Greta Zubaite; Christian Lüchtenborg; Timo Sachsenheimer; Britta Brügger; Matthias Mann; Wolfgang Baumeister; F Ulrich Hartl; Mark S Hipp; Rubén Fernández-Busnadiego
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.